Fumiki Oana
Division of Discovery Research
Kissei Pharmaceutical Company Ltd.
Hotaka
Nagano
Japan
Name/email consistency: high
- KTO-7924, a Beta3-adrenergic receptor agonist, reduces hyperglycemia, and protects beta-cells in the islets of langerhans of db/db mice. Oana, F., Takeda, H., Matsuzawa, A., Akahane, S., Hayashi, M., Tamura, T., Uehara, M., Isaji, M., Akahane, M. Endocr. Res. (2010)
- Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a beta3-adrenoceptor agonist. Oana, F., Takeda, H., Matsuzawa, A., Akahane, S., Isaji, M., Akahane, M. Eur. J. Pharmacol. (2005)
- DNA microarray analysis of white adipose tissue from obese (fa/fa) Zucker rats treated with a beta3-adrenoceptor agonist, KTO-7924. Oana, F., Homma, T., Takeda, H., Matsuzawa, A., Akahane, S., Isaji, M., Akahane, M. Pharmacol. Res. (2005)
- Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin. Oana, F., Takeda, H., Hayakawa, K., Matsuzawa, A., Akahane, S., Isaji, M., Akahane, M. Metab. Clin. Exp. (2005)